NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Medicaments primarily affecting the digestive system put up in measured doses or in forms/pk for retail sale, not elsewhere specified or included
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $496.08 to $826.81.. | |
| Does NSN 6505-01-391-6108 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Department Of The Army, Department Of The Air Force, and Department Of The Navy | |
| What is the NIIN of NSN 6505-01-391-6108? | |
| 013916108 or 01-391-6108 | |
| Does NSN 6505-01-391-6108 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-01-391-6108? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Jun 15, 1994 | |
Ld50 lc50 mixture: oral ld50 (rat): >2000 mg/kg
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: eyes: irritation following direct
contact w/this material.
explanation of carcinogenicity: none
effects of overexposure: irritation, redness, swelling, blurred vision,
pain, headache, drowsiness, lethargy, weakness, thirst.
First aid: skin/eyes: flush immediately w/water for 15 mins. Inhalation:
remove to fresh air. Give cpr if needed. Obtain medical attention
in all cases. Note to physician: this material is a
5-hydroxytryptamine- 3 antagonist w/no specific,
recommendedantidotes. Medical treatment should be symptomatic &
supportive.
Boiling pt: b.P. Text: 212f
melt/freeze pt: m.P/f.P text: 32f
vapor pres: negligible
vapor density: negligible
solubility in water: complete
appearance and odor: clear/colorless/sterile/nonpyrogenic/aqueous
solution for intravenous injection
percent volatiles by volume: >98
Stability indicator/materials to avoid: yes
stability condition to avoid: heat, freezing, direct sunlight & other
ignition sources.
hazardous decomposition products: in fire: toxic/corrosive gases.
Waste disposal methods: collect for recycling/recovery if possible.
dispose of iaw/federal, state & local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: granisetron hydrochloride *95-2*
cas: 107007-99-8
rtecs #: nk7882200
fraction by wt: 0.3%
ingred name: sodium chloride
cas: 7647-14-5
rtecs #: vz4725000
fraction by wt: 0.9%
ingred name: water
cas: 7732-18-5
rtecs #: zc0110000
fraction by wt: